24.04.2015 • NewsappointmentAstraZenecaCorden Pharma

Dr. Giorgio Bruno Appointed as New General Manager of Recipharm Italia

Dr. Giorgio Bruno has been appointed General Manager of Recipharm Italia. In this role, he will serve as CEO for all of Recipharm's Italian operating companies. Dr. Bruno has long established senior management experience from within the pharmaceutical industry, especially in the area of manufacturing. He has worked in both Italian and multinational pharmaceutical companies covering a wide range of disciplines. In particular he has had responsibility for quality and manufacturing at such companies including Parke Davis, AstraZeneca and Corden Pharma. Dr. Bruno also has held a number of positions within Italian based industry associations. He holds a Ph.D. in Pharmaceutical Chemistry and Technology from the University of Milan.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read